Plethora Solutions

Company Information

Registered Office

Hampden House
Monument Business Park
Warpsgrove Lane
OX44 7RW

Plethora's strategy is focused on bringing Fortacin™ to market via partners with the sales, marketing and distribution infrastructure to maximize the commercial potential from the product. In this respect, Plethora is engaged in dialogue with multiple parties, including major pharmaceutical companies, for a launch of Fortacin™, with the initial focus being on markets within the European Union, the United States (subject to regulatory approval) and other selected territories.

Registration Number

Plethora Solutions Holdings PLC is incorporated and registered in England and Wales with registration number 05341336 and its main country of operation is the UK.

This Product is a proprietary development stage pharmaceutical although the European MAA has been authorized by the European Commission. Information contained on this website is provided for business development and investor relations purposes only. Patients who suffer or believe they suffer from PE should contact their physician in the first instance.